
Join to view full profile
1275 York AveNew York, NY 10065
Phone+1 212-639-2000
Dr. Roshal is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematopathology, 2009 - 2010
University of WashingtonResidency, Pathology-Anatomic and Clinical, 2005 - 2008
University of Rochester School of Medicine and DentistryClass of 2005
Certifications & Licensure
NJ State Medical License 2021 - 2027
NY State Medical License 2010 - 2027
WA State Medical License 2007 - 2010
American Board of Pathology Pathology - Clinical
American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Mini-hyper-CVD with low-dose inotuzumab ozogamicin is an effective induction strategy for adults with immunomodulatory drug-associated B-cell acute lymphoblastic leuke...Leora Boussi, Ettaib El Marabti, Brian Shaffer, Heather Landau, Yanming Zhang
Leukemia Research. 2026-09-29 - Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.Magdalena Corona, Aaron Gillmor, Kimon V Argyropoulos, Teng Fei, Maria Isabel Sotelo-Alva
Blood Cancer Discovery. 2026-08-31 - Deep Learning Enables Automated Detection of Mature B-Cell Neoplasms by Flow Cytometry.Sulov Chalise, Mikhail Roshal, Qi Gao, Anyi Li, Ahmet Dogan
Modern Pathology. 2026-08-11
Journal Articles
- Acquired Resistance to IDH Inhibition Through Trans or Cis Dimer-Interface MutationsMartin S Tallman, Eytan M Stein, Alan H Shih, Maria E Arcila, Andrew M Intlekofer, Craig B Thompson, Mikhail Roshal, Nature
Abstracts/Posters
- Acute Leukemia with Lineage Infidelity: Mixed Phenotype AML Exhibits a Distinct Immunophenotype with Clinical Features Overlapping Mixed Phenotype Acute LeukemiaMikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...Mikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Plasma Cell Myeloma Residual Disease Quantitation Using a Next-Generation Sequencing-Based IGH Clonal Rearrangement Assay with the Aid of a Spike-in Clonal SequenceMikhail Roshal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Loss of Plasmacytoid Dendritic Cell Differentiation Is Highly Predictive for Persistent Measurable Residual Disease and Poor Outcomes in Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Circulating Lymphoma Cells in Mycosis Fungoides/Sezary Syndrome Show Heterogeneity of the Cell-of-Origin and Variable PD-1 Expression By Flow Cytometric Analysis2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Understanding the Origins of Hodgkin Lymphoma Cells Could Lead to Better DiagnosticsApril 25th, 2026
Understanding Hodgkin Lymphoma Cell Origins Could Yield Better DiagnosticsApril 29th, 2026
Understanding the Origins of Hodgkin Lymphoma Cells Could Lead to Better DiagnosticsApril 29th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: